the question handbill
KPV Peptide: Frequently Asked Questions
Direct answers drawn from the published literature and the audited FDA record — what is known, what is preclinical, and what has no human answer yet.
What does KPV peptide do?
KPV is the C-terminal tripeptide (residues 11-13) of alpha-MSH that retains the parent hormone's anti-inflammatory activity while lacking its pigmentary action [4]. In research models it suppresses NF-kB and MAP-kinase signaling and reduces pro-inflammatory cytokine production [1], and the effect appears largely melanocortin-receptor-independent [2].
What is KPV peptide?
KPV (Lys-Pro-Val) is a linear tripeptide corresponding to residues 11-13 of alpha-melanocyte-stimulating hormone, studied as a melanocortin-derived anti-inflammatory peptide [4]. Its formula is C16H30N4O4 and its molecular weight is 342.44 Da [1].
What is KPV?
KPV stands for the tripeptide lysine-proline-valine, the C-terminal fragment of alpha-MSH studied for anti-inflammatory and gut/epithelial signaling [4]. It is not an independently circulating hormone.
How does KPV reduce inflammation?
In research models KPV dampens inflammation mainly by inhibiting NF-kB and MAP-kinase signaling and lowering pro-inflammatory cytokine secretion [1]; the effect appears largely melanocortin-receptor-independent and is retained in MC1R-deficient models [2].
How is KPV related to alpha-MSH?
KPV is the C-terminal tripeptide (residues 11-13) of alpha-melanocyte-stimulating hormone; it preserves the parent hormone's anti-inflammatory activity but lacks its pigmentary (melanogenic) action [4].
Does KPV cause skin pigmentation or tanning like other melanocortins?
KPV's defining feature in the literature is anti-inflammatory action without pigmentary effect; unlike melanocortin agonists used for tanning, the C-terminal KPV fragment lacks the melanogenic activity of full alpha-MSH [4].
What is PepT1 and why does it matter for KPV?
PepT1 (SLC15A1) is an intestinal di/tripeptide transporter that carries KPV directly into epithelial cells; it is upregulated in inflamed gut tissue, which makes it a route to target KPV to the inflamed colon [1].
What is KPV peptide used for?
In the published literature KPV is studied as an anti-inflammatory agent, most extensively in murine colitis/IBD models, and also in corneal and skin wound-repair and antimicrobial research; it has no approved human use [1][2][6][9].
What is KPV used for?
In research, KPV is used as an anti-inflammatory probe and candidate, most heavily in gut/colitis models via PepT1-mediated uptake, with additional wound-healing, skin, and antimicrobial studies [1][6][9].
What is KPV peptide good for?
Research interest centers on anti-inflammatory and gut/epithelial signaling — colitis models via PepT1 uptake — plus exploratory wound-healing and antimicrobial findings; all evidence is preclinical [1][6][9].
What are the benefits of KPV peptide?
Reported research findings include reduced colonic inflammation in mouse colitis [2], accelerated corneal re-epithelialization in rabbits (8/8 by 60 hours) [6], and downregulated inflammatory signaling across cell types [1][8]; these are preclinical findings, not demonstrated human benefits.
Is KPV peptide worth it?
That is an evaluative question the literature cannot answer: KPV's evidence base is mechanistic and preclinical, with no human trials, so any value judgment for human use would outrun the data [1][16].
Can you take KPV and BPC-157 together?
No controlled study has evaluated a KPV plus BPC-157 combination in humans; the research record contains no data on co-administration of these two peptides, so no research-based combination guidance exists.
Is KPV peptide safe?
No published human clinical trials of KPV exist, so human safety is unestablished; what is known comes from in vitro and animal studies [1][2]. It is a research chemical for laboratory use only [20].
Who should not take KPV peptide?
KPV is not approved for human use and has no validated human dosing or safety data, so the literature does not define a human use population; it is sold by research suppliers for laboratory use only [16][20].
How long does it take KPV peptide to work?
There is no human timeline; in animal models effects were measured over days — for example, complete corneal re-epithelialization by 60 hours in a rabbit study [6] — but these do not translate to a human onset time.
How quickly does KPV peptide work?
Onset is model-dependent in animal research and undefined in humans; as a peptidase-labile tripeptide, free KPV is expected to be rapidly degraded, which is why much research uses stabilizing formulations [1][5].
Can you take KPV every day?
No human dosing schedule has been established. Research doses vary widely by model — for example, ~10 nM in vitro, ~100 uM in mouse drinking water, and multiple daily topical eye-drop doses in rabbits [1][6].
How often do I inject KPV peptide?
Research administration in the literature is largely oral (drinking water, encapsulated nanoparticles) or topical, not injection [1][5][6]; no validated human injection frequency exists.
How long should I take KPV peptide for?
No human treatment duration is established. Animal studies ran over days to weeks depending on the model [1][6]; these durations are not human dosing recommendations.
What is KPV peptide dosage?
There is no established human dose. Reported research concentrations include ~10 nM in vitro, ~100 uM in mouse drinking water, and 1-10 mg/mL topical eye drops in rabbits [1][6].
What are KPV peptide side effects?
No human side-effect profile has been published because there are no human trials; safety is characterized only in preclinical models, and KPV remains a research-only chemical [16][20].
Is KPV legal?
KPV is not an FDA-approved drug and is sold as a research chemical for laboratory use only; it is not approved as a drug or dietary supplement in any major jurisdiction [16][20]. Under the FD&C Act it could be used in 503A compounding only if it were on FDA's 503A bulks list or otherwise eligible, and KPV is currently a candidate under PCAC evaluation rather than a listed substance [16][18]. This is general information, not legal advice.
Can you get KPV from a compounding pharmacy?
Legally compounded access requires an eligible ingredient plus a licensed-prescriber evaluation and a valid, patient-specific prescription routed through a 503A pharmacy or 503B outsourcing facility, with telehealth as a possible front-end consultation channel [19]. Because KPV is currently a candidate under FDA evaluation rather than a listed bulk substance, its eligibility for routine 503A compounding is exactly the open question the July 2026 PCAC meeting is scheduled to examine; no outcome should be assumed [16][18].
What is the FDA 503A status of KPV?
KPV is a bulk drug substance "being considered for inclusion on the 503A Bulks List," individually named on the FDA Pharmacy Compounding Advisory Committee agenda for the meeting scheduled July 23-24, 2026, in both free base and acetate forms [18]. The audited FDA reference does not assign KPV a numbered 503A Category; its present-tense status is research peptide, not FDA-approved, scheduled for PCAC evaluation — a step in evaluation, not a final listing decision [16][18]. For the full picture, see KPV legal status and 503A access.